Treace Medical Concepts Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -1,457.3% | – | – | – | – | -172.7% | – | – | – | -164.9% | – | |
| – | +13.1% | +7.9% | +10.8% | +1.9% | +3.7% | +10.0% | +0.0% | +12.8% | +3.7% | -68.8% | +110.0% | – | |
| – | +13.1% | +26.2% | -9.0% | +17.2% | +8.3% | +1.6% | +10.2% | -16.5% | -5.5% | +6.3% | -19.6% | – | |
| – | -294.1% | – | -355.5% | – | – | – | -80.7% | -413.3% | – | – | -92.4% | – | |
| – | -35.8% | +74.7% | -56.0% | +65.6% | +7.4% | +15.3% | +34.5% | -41.1% | -14.6% | +27.7% | -28.1% | – | |
| – | +8.9% | -24.9% | +496.9% | -74.3% | -40.6% | -155.4% | +72.0% | – | +10.6% | -180.9% | – | – | |
| – | – | +1,723.1% | – | – | – | – | – | – | – | – | – | – | |
| – | +3.8% | -212.1% | – | -97.4% | +225.0% | -1,184.6% | – | -101.0% | – | -142.1% | – | – | |
| – | – | -164.0% | – | -168.6% | – | – | -363.1% | – | – | -138.5% | – | – | |
| – | – | – | – | – | – | – | -1,293.4% | – | – | – | -265.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.